# India Rapid Diagnostics Market > India Rapid Diagnostics Market Research Report By Application (Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing) and By Product Type (Over the Counter (OTC) Kits, Professional Kits) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.28% - **2024:** $ 2,500 Million - **2025:** $ 2,707 Million - **2035:** $ 6,000 Million - **Key Players:** Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), BD (US), Cepheid (US), bioMérieux (FR), QuidelOrtho Corporation (US), Hologic (US) **Report ID:** MRFR/MED/43670-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-rapid-diagnostics-market-45350 --- ## Market Summary ## **India Rapid Diagnostics Market Overview** As per MRFR analysis, the India Rapid Diagnostics Market Size was estimated at 1.73 (USD Billion) in 2023.The India Rapid Diagnostics Market Industry is expected to grow from 2.51(USD Billion) in 2024 to 5.96 (USD Billion) by 2035. The India Rapid Diagnostics Market CAGR (growth rate) is expected to be around 8.174% during the forecast period (2025 - 2035). **Key India Rapid Diagnostics Market Trends Highlighted** The India Rapid Diagnostics Market is significantly expanding on account of the growing requirement for point-of-care testing services across several healthcare facilities. There is also a growing adoption of rapid diagnostic tests across hospitals, clinics, and patients’ homes due to the increasing prevalence of infectious diseases along with the need for effective and efficient diagnostics. In addition, the development and funding of basic healthcare services and facilities by the government is an important driver of the market. The National Health Mission and other government efforts for better control and prevention of diseases are promoting the use of rapid diagnostic tools for public health issues in India. The Indian market presents a lot of opportunities because the case of increased technological innovation and better awareness among the healthcare professionals and general public inspires new diagnostic products. Increased health awareness after the pandemic has led to the adoption and reliance on rapid diagnostics and innovative solutions. This aids local manufacturers and startups ready to meet the needs of the people, even those in rural areas where orthodox hospitals and laboratories face a lot of challenges. These days, there is a clear movement toward telehealth services that combine rapid diagnostic tests with virtual consultations, where patients can quickly have their test results and medical attention facilitated. Moreover, the recent tendency towards the integration of the services provided by the public and private sectors enables better and faster diagnosis to be done all over the country. As the enacting of the laws relating diagnostic tools changes, there is likely to be an increasing scope of for collaboration and investments which will further propel the rapid diagnostics industry in India. **India Rapid Diagnostics Market Drivers** **Rising Prevalence of Infectious Diseases** The increasing burden of infectious diseases in India serves as a significant driver for the India Rapid Diagnostics Market Industry. For instance, the National Health Mission reported a rise in the cases of tuberculosis, with approximately 2.64 million registered cases in India in 2020, indicating a critical demand for rapid diagnostic solutions. This alarming trend showcases a need for efficient testing mechanisms to control outbreaks and improve patient outcomes.The ability to diagnose and treat infectious diseases promptly is crucial for public health management, thereby propelling the growth of rapid diagnostics. Furthermore, the review from the Indian Council of Medical Research (ICMR) suggests that over 1.5 million people in India are diagnosed with malaria each year, reinforcing the urgent requirement for rapid testing solutions in rural and urban healthcare systems. **Government Initiatives for Healthcare Improvement** The Indian government has implemented various initiatives aimed at improving healthcare infrastructure which enhances the prospects for the India Rapid Diagnostics Market Industry. Programs like Ayushman Bharat, which aims to provide health insurance to over 500 million people, significantly increase healthcare accessibility. The allocation of approximately USD 13 billion in the 2020-2021 budget towards health has catalyzed investments in diagnostics, particularly in rural areas where access to diagnostic facilities is limited.Such initiatives not only create a conducive environment for rapid diagnostics but also facilitate partnerships with established organizations like the WHO and various tech companies to introduce innovative testing solutions, ultimately boosting market growth. **Technological Advancements in Diagnostic Tools** Innovations in technology have significantly impacted the rapid diagnostics landscape in India, acting as a robust growth driver for the India Rapid Diagnostics Market Industry. The development of point-of-care testing (POCT) devices, which provide immediate results, has gained momentum. According to industry reports, the market for POCT is expected to grow at a rate of 15-20% annually due, in part, to advancements made by companies such as Mylab Discovery Solutions, a prominent Indian player known for its rapid RT-PCR testing kits during the COVID-19 pandemic.The push towards technological integration in healthcare challenges traditional diagnostics, offering quicker, more accessible testing options critical for timely disease management across India. This creates opportunities for expansion within the market, leveraging both public and private sector investment. **India Rapid Diagnostics Market Segment Insights** **Rapid Diagnostics Market Application Insights** The India Rapid Diagnostics Market is rapidly evolving, particularly within the Application segment, which plays a pivotal role in ensuring accessible healthcare solutions across the nation. This segment encompasses a variety of crucial analytical methods, including Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, and Toxicology Testing.  Each of these applications serves distinct yet significant needs in the healthcare landscape. Blood Glucose Testing has become essential for the management of diabetes, catering to a growing diabetic population in India. With an increasing number of people being diagnosed with this chronic illness, the demand for accurate and quick monitoring solutions continues to rise, promoting better health management practices.Infectious Disease Testing is also gaining traction, especially in the context of public health initiatives aimed at combating prevalent diseases such as tuberculosis, malaria, and HIV.  The ability to swiftly identify infections supports timely intervention and treatment, crucial for containing outbreaks and improving overall community health metrics. Similarly, Cardiometabolic Testing plays a vital role in assessing cardiovascular and metabolic health, which is critical in a country experiencing a rise in lifestyle-related diseases due to urbanization and changing diets.Pregnancy Fertility Testing remains a focal application, with many couples seeking timely answers for family planning and reproductive health.  This application not only highlights the importance of early detection but also significant advancements in testing technologies that facilitate patient convenience. On the other hand, Fecal Occult Blood Testing provides screenings for colorectal cancer, an essential part of preventive healthcare strategies, especially given India's growing emphasis on early cancer detection.Coagulation Testing, crucial for diagnosing bleeding disorders and monitoring patients on anticoagulants, addresses an integral healthcare aspect, ensuring safe treatment protocols for individuals with specific medical needs. Lastly, Toxicology Testing assists in the identification of substance abuse and exposure to harmful chemicals, playing an essential role in public safety and health regulation.  The India Rapid Diagnostics Market is characterized by the flexibility and adaptability of these applications, which integrate new technologies to meet the changing dynamics of healthcare needs in India, capturing not only the attention of healthcare professionals but increasingly, patients themselves who are seeking self-monitoring solutions. The rising prevalence of various health issues, coupled with the urban population's growing demand for accessible and efficient diagnostic systems, positions the Application segment as a vital component supporting the overall growth and expansion of India's healthcare landscape. The strategic prioritization of rapid and reliable diagnostic applications is crucial to driving significant health outcomes and advancing India's healthcare quality. **Rapid Diagnostics Market Product Type Insights** The India Rapid Diagnostics Market is characterized by a diverse range of product types, with Over the Counter (OTC) Kits and Professional Kits emerging as key segments. OTC Kits, commonly accessible to consumers without the need for a prescription, enable rapid testing for various conditions, enhancing self-diagnosis and health management. This segment has seen notable demand due to the increasing awareness of health issues and the emphasis on preventative care among the Indian population. Meanwhile, Professional Kits cater to healthcare providers, offering reliable solutions for accurate diagnosis in clinical settings.These kits play a critical role in streamlining patient management and improving healthcare outcomes. The growth of both segments is fueled by rising healthcare expenditure, increased prevalence of infectious diseases, and advancements in technology, alongside the growing trend of digital health solutions in India. The adaptability and convenience of OTC Kits combined with the trusted efficacy of Professional Kits position both segments favorably within the market, reflecting robust potential in enhancing diagnostic accessibility across various demographics in the country.The expanding healthcare infrastructure and supportive government initiatives further bolster the prospects for growth in the India Rapid Diagnostics Market. **India Rapid Diagnostics Market Key Players and Competitive Insights** The India Rapid Diagnostics Market is witnessing significant growth, driven by an increased prevalence of infectious diseases and a rising demand for quick and accurate diagnostic solutions. The competitive landscape in this market is characterized by both global players and regional companies that are striving to innovate and offer a diverse range of products. The market is influenced by various factors including technological advancements, changing healthcare policies, and an expanding healthcare infrastructure that emphasizes the importance of rapid testing. As the healthcare sector continues to evolve, companies are focusing on strategic partnerships, collaborations, and advancements in diagnostics technology to enhance their market presence and meet the growing needs of healthcare providers and patients.Medtronic has established a notable presence in the India Rapid Diagnostics Market by capitalizing on its strengths in medical technology and innovation. The company’s commitment to providing high-quality diagnostics solutions has enabled it to cater effectively to the evolving healthcare demands in India.  Medtronic's strong focus on research and development has led to the introduction of state-of-the-art products tailored for the Indian population, addressing specific health challenges. Moreover, its efficient distribution network enhances its ability to deliver timely diagnostic solutions across various regions of India, thereby solidifying its position as a key player in the market. The company also engages in educational initiatives and training for healthcare professionals, further strengthening its reputation and influence in the rapid diagnostics space.Abbott plays a crucial role in the India Rapid Diagnostics Market, known for its broad portfolio of innovative diagnostic products and services.  The company's key offerings include rapid tests for infectious diseases, molecular diagnostics, and point-of-care testing solutions, which cater to the diverse needs of Indian healthcare providers. Abbott's robust market presence is underpinned by a strong distribution network that ensures accessibility to its products across urban and rural areas. The company has consistently focused on strategic partnerships and collaborations with local healthcare institutions, allowing them to enhance their market reach.  Furthermore, Abbott has made notable investments in research and development specific to the Indian market, enabling them to introduce products that align with local health conditions. With a commitment to excellence and quality, Abbott continues to strengthen its position within the India Rapid Diagnostics Market. **Key Companies in the India Rapid Diagnostics Market Include:** - Medtronic - Abbott - Dr. Lal PathLabs - Mylab Discovery Solutions - Hewlett Packard Enterprise - Arkray - ZyBio - Alere - Thermo Fisher Scientific - Roche - Siemens Healthineers - Srinivasa Diagnostics - BioRad Laboratories - Panbio - BD **India Rapid Diagnostics Market Industry Developments** The India Rapid Diagnostics Market is witnessing significant developments, particularly in the context of emerging health technologies and increasing demand due to the ongoing focus on healthcare. In October 2023, Medtronic announced a new product launch aimed at enhancing rapid diagnostic capabilities, indicating a growth trajectory in this sector. Abbott's advancements in molecular diagnostics have been pivotal, particularly with their rapid testing solutions garnering attention for infectious diseases. In recent times, Dr. Lal PathLabs and Mylab Discovery Solutions have also expanded their portfolios to include innovative rapid testing methodologies.  Notably, Siemens Healthineers and Thermo Fisher Scientific are continuously investing in RD to bolster their market presence. Noteworthy mergers include Alere's acquisition by Abbott, which has strengthened Abbott's position in the rapid diagnostics arena. The overall market is projected to grow significantly, driven by increased government initiatives and funding in the healthcare sector, particularly following the pandemic.  In the last two years, the demand for rapid testing solutions has surged, underscoring the importance of timely diagnostics in India's healthcare landscape. This evolution, backed by various stakeholders, is essential for addressing public health challenges effectively. **India Rapid Diagnostics Market Segmentation Insights** - **Rapid Diagnostics Market Application Outlook** - Blood Glucose Testing - Infectious Disease Testing - Cardiometabolic Testing - PregnancyFertility Testing - Fecal Occult Blood Testing - Coagulation Testing - Toxicology Testing - **Rapid Diagnostics Market Product Type Outlook** - Over the Counter (OTC) Kits - Professional Kits ## Market Drivers ### Government Initiatives and Funding Government initiatives aimed at enhancing healthcare infrastructure significantly impact the rapid diagnostics market. The Indian government has launched various programs to improve healthcare access and affordability, which includes funding for diagnostic services. For instance, the National Health Mission allocates substantial resources to strengthen healthcare delivery systems, including diagnostics. This support is crucial for the rapid diagnostics market, as it encourages the development and distribution of advanced diagnostic tools. Furthermore, public-private partnerships are emerging, fostering innovation and expanding the reach of rapid diagnostic solutions across urban and rural areas. Such initiatives are expected to bolster market growth and accessibility. ### Increase in Health Insurance Coverage The expansion of health insurance coverage in India is a crucial factor influencing the rapid diagnostics market. With more individuals gaining access to health insurance, there is a growing willingness to seek diagnostic services. This trend is likely to increase the utilization of rapid diagnostic tests, as insured patients are more inclined to undergo necessary screenings and tests. The rapid diagnostics market stands to benefit from this shift, as it aligns with the increasing demand for accessible and affordable healthcare solutions. As health insurance penetration continues to rise, the market is expected to experience substantial growth, driven by the need for timely and effective diagnostic services. ### Rising Prevalence of Chronic Diseases The increasing incidence of chronic diseases in India is a pivotal driver for the rapid diagnostics market. With conditions such as diabetes, cardiovascular diseases, and respiratory disorders on the rise, there is a growing need for timely and accurate diagnostic solutions. According to recent health statistics, chronic diseases account for approximately 60% of all deaths in India, underscoring the urgency for effective monitoring and management. The rapid diagnostics market is responding to this demand by developing innovative testing solutions that facilitate early detection and treatment, thereby improving patient outcomes. This trend is likely to continue as healthcare providers and patients alike seek efficient diagnostic tools to manage chronic conditions effectively. ### Technological Integration in Healthcare The integration of advanced technologies in healthcare is transforming the rapid diagnostics market. Innovations such as artificial intelligence, machine learning, and telemedicine are enhancing the accuracy and efficiency of diagnostic tests. These technologies enable healthcare providers to analyze data more effectively, leading to quicker decision-making and improved patient care. The rapid diagnostics market is increasingly adopting these technologies to streamline operations and enhance service delivery. As healthcare systems in India continue to evolve, the demand for technologically advanced diagnostic solutions is expected to rise, driving market growth and improving healthcare outcomes. ### Growing Awareness of Preventive Healthcare There is a notable shift towards preventive healthcare in India, which serves as a significant driver for the rapid diagnostics market. As individuals become more health-conscious, the demand for early detection and preventive measures is increasing. This trend is reflected in the rising number of health check-up camps and awareness programs organized by both governmental and non-governmental organizations. The rapid diagnostics market is capitalizing on this shift by offering user-friendly and cost-effective testing solutions that empower individuals to take charge of their health. The market is projected to grow as more people recognize the importance of regular health screenings and timely interventions. ## Future Outlook The [Rapid Diagnostics Market](https://www.marketresearchfuture.com/reports/rapid-diagnostics-market-11687) in India is projected to grow at 8.28% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare demands, and rising awareness. **New opportunities:** - Development of portable diagnostic devices for remote areas. - Integration of AI for enhanced diagnostic accuracy. - Expansion of telehealth services incorporating rapid testing solutions. By 2035, the market is expected to achieve substantial growth, driven by innovation and increased accessibility. ## Segment Insights ### By Product: Over-the-Counter (OTC) Kits (Largest) vs. Professional Kits (Fastest-Growing) In the India rapid diagnostics market, Over-the-Counter (OTC) Kits hold a significant market share, driven by consumer preference for convenience and accessibility. These kits allow individuals to perform tests at home without needing professional assistance, catering to a growing demand for self-testing options. Conversely, Professional Kits have also carved out a notable share, especially within healthcare institutions, where accuracy and reliability are paramount. The growth trends indicate that while OTC Kits dominate the market currently, Professional Kits are emerging as the fastest-growing segment. Factors driving this growth include an increase in healthcare investments, rising awareness for early diagnosis, and an expansion in healthcare facilities that require efficient diagnostic solutions. There is a notable shift towards using professional quality tests, leading to enhanced adoption rates in various healthcare settings. Over-the-Counter (OTC) Kits (Dominant) vs. Professional Kits (Emerging) Over-the-Counter (OTC) Kits are positioned as the dominant force in the India rapid diagnostics market, widely favored for their user-friendliness and ability to deliver quick test results for a variety of health concerns. They appeal to a broad consumer base seeking hassle-free solutions. On the other hand, Professional Kits represent the emerging segment, gaining traction among healthcare facilities that demand high accuracy levels. These kits are typically used in clinical settings and are regarded for their reliability and efficacy. Both segments are crucial, with OTC Kits leading the market while Professional Kits exhibit robust growth due to increasing healthcare needs and advancements in diagnostic technology. ### By Application: Blood Glucose Testing (Largest) vs. Infectious Disease Testing (Fastest-Growing) The application segment in the India rapid diagnostics market showcases a competitive landscape with Blood Glucose Testing leading the market due to the increasing prevalence of diabetes. This segment's dominance can be attributed to the rising awareness of diabetic management and advancements in testing technology. Additionally, Infectious Disease Testing is gaining momentum, driven by the need for rapid testing solutions, especially in light of recent health crises, making it a significant player in the market. Growth trends indicate that while Blood Glucose Testing remains strong, Infectious Disease Testing is on an accelerated growth trajectory. Key drivers include increasing healthcare expenditures, advancements in point-of-care testing technologies, and a growing consumer preference for rapid testing solutions. The government's initiatives to enhance healthcare access further bolster the adoption of these applications, setting the stage for robust growth over the coming years. Blood Glucose Testing (Dominant) vs. Infectious Disease Testing (Emerging) Blood Glucose Testing has established itself as the dominant application in the India rapid diagnostics market, primarily due to the high prevalence of diabetes among the population. This segment benefits from innovative technologies that allow for more efficient and comfortable testing processes. On the other hand, Infectious Disease Testing is an emerging segment that is rapidly gaining market traction, driven by factors such as the explosion of new infectious diseases and the need for faster response times in diagnostics. The expanding healthcare infrastructure and increased demand for timely and accurate testing solutions are pushing the growth of this segment, positioning it as a critical player alongside the well-entrenched Blood Glucose Testing. ## Competitive Benchmarking The rapid diagnostics market in India is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for timely diagnostic solutions. Key players such as Abbott Laboratories (US), Roche Diagnostics (CH), and Siemens Healthineers (DE) are at the forefront, each adopting distinct strategies to enhance their market presence. Abbott Laboratories (US) focuses on innovation, particularly in point-of-care testing, which aligns with the growing trend towards decentralized healthcare. Roche Diagnostics (CH) emphasizes partnerships with local healthcare providers to expand its reach, while Siemens Healthineers (DE) invests heavily in digital transformation to streamline operations and improve diagnostic accuracy. Collectively, these strategies contribute to a competitive environment that is increasingly focused on rapid, reliable, and accessible diagnostic solutions.In terms of business tactics, companies are localizing manufacturing to reduce costs and improve supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where multiple players vie for market share. The collective influence of these key players shapes a landscape where innovation and operational efficiency are paramount, allowing them to respond swiftly to market demands and regulatory changes. In October Abbott Laboratories (US) announced the launch of a new rapid diagnostic test for infectious diseases, which is expected to significantly enhance testing capabilities in rural areas. This strategic move not only reinforces Abbott's commitment to innovation but also addresses the pressing need for accessible healthcare solutions in underserved regions. The introduction of this test is likely to strengthen Abbott's market position and expand its customer base. In September Roche Diagnostics (CH) entered into a strategic partnership with a leading Indian healthcare provider to co-develop diagnostic solutions tailored to local needs. This collaboration is indicative of Roche's strategy to leverage local expertise and resources, thereby enhancing its product offerings and market penetration. Such partnerships are crucial in navigating the complexities of the Indian healthcare landscape, where localized solutions are often more effective. In August Siemens Healthineers (DE) unveiled a new AI-driven diagnostic platform aimed at improving the accuracy and speed of test results. This platform integrates advanced analytics and machine learning, positioning Siemens as a leader in the digital transformation of diagnostics. The strategic importance of this development lies in its potential to not only enhance diagnostic capabilities but also to set a new standard for efficiency in the market. As of November current trends in the rapid diagnostics market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing their competitive edge. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to a focus on innovation, technological advancement, and supply chain reliability. This shift suggests a future where companies that prioritize these elements will likely emerge as leaders in the evolving landscape. ## Recent News & Developments The India Rapid Diagnostics Market is witnessing significant developments, particularly in the context of emerging health technologies and increasing demand due to the ongoing focus on healthcare. In October 2023, Medtronic announced a new product launch aimed at enhancing rapid diagnostic capabilities, indicating a growth trajectory in this sector. Abbott's advancements in molecular diagnostics have been pivotal, particularly with their rapid testing solutions garnering attention for infectious diseases. In recent times, Dr. Lal PathLabs and Mylab Discovery Solutions have also expanded their portfolios to include innovative rapid testing methodologies.  Notably, Siemens Healthineers and Thermo Fisher Scientific are continuously investing in RD to bolster their market presence. Noteworthy mergers include Alere's acquisition by Abbott, which has strengthened Abbott's position in the rapid diagnostics arena. The overall market is projected to grow significantly, driven by increased government initiatives and funding in the healthcare sector, particularly following the pandemic.  In the last two years, the demand for rapid testing solutions has surged, underscoring the importance of timely diagnostics in India's healthcare landscape. This evolution, backed by various stakeholders, is essential for addressing public health challenges effectively. ## Report Scope | MARKET SIZE 2024 | 2500.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 2707.0(USD Million) | | MARKET SIZE 2035 | 6000.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.28% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), BD (US), Cepheid (US), bioMérieux (FR), QuidelOrtho Corporation (US), Hologic (US) | | Segments Covered | Product, Application | | Key Market Opportunities | Integration of artificial intelligence in rapid diagnostics enhances accuracy and speed of disease detection. | | Key Market Dynamics | Technological advancements drive rapid diagnostics market growth, enhancing accuracy and speed of disease detection in India. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the rapid diagnostics market in India as of 2024?** A: The overall market valuation was $2500.0 Million in 2024. **Q: What is the projected market valuation for the rapid diagnostics market in India by 2035?** A: The projected valuation for 2035 is $6000.0 Million. **Q: What is the expected CAGR for the rapid diagnostics market in India during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 8.28%. **Q: Which companies are considered key players in the India rapid diagnostics market?** A: Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, BD, Cepheid, bioMérieux, QuidelOrtho Corporation, and Hologic. **Q: What are the main product segments in the India rapid diagnostics market?** A: The main product segments are Over-the-Counter (OTC) Kits and Professional Kits. **Q: What was the market size for Over-the-Counter (OTC) Kits in 2024?** A: The market size for Over-the-Counter (OTC) Kits was $1000.0 Million in 2024. **Q: What is the projected market size for Professional Kits by 2035?** A: The projected market size for Professional Kits by 2035 is $3600.0 Million. **Q: Which application segment had the highest market size in 2024?** A: In 2024, the Infectious Disease Testing segment had the highest market size at $600.0 Million. **Q: What is the expected market size for Blood Glucose Testing by 2035?** A: The expected market size for Blood Glucose Testing by 2035 is $600.0 Million. **Q: How does the market for Cardiometabolic Testing compare to other application segments in 2024?** A: In 2024, the market for Cardiometabolic Testing was $400.0 Million, indicating a robust position among other application segments. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-rapid-diagnostics-market-45350*